Who owns Century Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IPSC from SEC Form 13F filings across 102 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 102 institutions disclosed 163.1M shares of Century Therapeutics, Inc. worth $277.3M — about 79% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
102
13F holders
$277.3M
value, 2026 filers
79%
of shares outstanding (163.1M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IPSC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 17.8M | $30.4M | 0.3% | 8.6% | 0.0% |
| 2 | TCG Crossover Management, LLC | 17.8M | $30.4M | 0.9% | 8.6% | 0.0% |
| 3 | Versant Venture Management, LLC | 12.2M | $20.8M | 19.1% | 5.9% | 0.0% |
| 4 | Deep Track Capital, LP | 9.5M | $16.2M | 0.3% | 4.6% | 0.0% |
| 5 | BlackRock, Inc. | 8.9M | $15.2M | 0.0% | 4.3% | +9.9% |
| 6 | Commodore Capital LP | 8.7M | $14.9M | 1.2% | 4.2% | 0.0% |
| 7 | Venrock Adviser, LLC | 8.7M | $14.9M | 0.7% | 4.2% | 0.0% |
| 8 | RTW INVESTMENTS, LP | 8.7M | $14.9M | 0.1% | 4.2% | 0.0% |
| 9 | MILLENNIUM MANAGEMENT LLC | 6.1M | $10.4M | 0.0% | 2.9% | +44.3% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 5.7M | $9.7M | 0.0% | 2.8% | -0.2% |
| 11 | Woodline Partners LP | 5.7M | $9.7M | 0.0% | 2.7% | +33.0% |
| 12 | Balyasny Asset Management L.P. | 5.5M | $9.4M | 0.0% | 2.7% | 0.0% |
| 13 | Point72 Asset Management, L.P. | 5.1M | $8.7M | 0.0% | 2.5% | +2.6% |
| 14 | Seven Fleet Capital Management LP | 4.4M | $6.1M | 1.2% | 2.1% | +1.7% |
| 15 | Trails Edge Capital Partners, LP | 4.1M | $7.1M | 1.0% | 2% | 0.0% |
| 16 | Spruce Street Capital LP | 4.1M | $6.9M | 1.1% | 2% | 0.0% |
| 17 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.8M | $6.5M | 0.0% | 1.8% | 0.0% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 2.9M | $4.9M | 0.0% | 1.4% | -3.6% |
| 19 | STEMPOINT CAPITAL LP | 2.6M | $4.4M | 0.8% | 1.2% | +19.5% |
| 20 | TWO SIGMA INVESTMENTS, LP | 2.6M | $4.4M | 0.0% | 1.2% | -5.1% |
| 21 | STATE STREET CORP | 2.5M | $4.3M | 0.0% | 1.2% | +36.4% |
| 22 | DAFNA Capital Management LLC | 2.4M | $4.1M | 0.9% | 1.2% | -0.6% |
| 23 | NORTHERN TRUST CORP | 1.5M | $2.5M | 0.0% | 0.7% | -7.3% |
| 24 | Rock Springs Capital Management LP | 1.3M | $2.2M | 0.1% | 0.6% | 0.0% |
| 25 | Casdin Capital, LLC | 1.2M | $2.1M | 0.1% | 0.6% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.